Early (99m)Tc-ethylcysteinate dimer brain SPECT patterns in the acute phase of stroke as predictors of neurological recovery

Accurate prediction of outcome in acute stroke would help in identifying subgroups of patients for therapeutic trials and intravenous thrombolysis. The purpose of this study was to prospectively test the hypothesis that brain SPECT, with (99m)Tc-L, L-ethylcysteinate dimer (ECD), a tracer sensitive t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cerebrovascular diseases (Basel, Switzerland) Switzerland), 2000-09, Vol.10 (5), p.364-373
Hauptverfasser: Mahagne, M H, Darcourt, J, Migneco, O, Fournier, J P, Thiercelin, D, Ducoeur, S, Bertrand, F, Bussière, F, Chatel, M, Baron, J C
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 373
container_issue 5
container_start_page 364
container_title Cerebrovascular diseases (Basel, Switzerland)
container_volume 10
creator Mahagne, M H
Darcourt, J
Migneco, O
Fournier, J P
Thiercelin, D
Ducoeur, S
Bertrand, F
Bussière, F
Chatel, M
Baron, J C
description Accurate prediction of outcome in acute stroke would help in identifying subgroups of patients for therapeutic trials and intravenous thrombolysis. The purpose of this study was to prospectively test the hypothesis that brain SPECT, with (99m)Tc-L, L-ethylcysteinate dimer (ECD), a tracer sensitive to cell function, performed in the first hours after stroke onset, adds predictive power to concomitant neurological evaluation. Twenty-four patients with a first-ever middle cerebral artery stroke were prospectively studied with ECD-SPECT within 12 h after stroke onset. Neurological evaluation was performed using Orgogozo's scale at admission and 3 months later in order to calculate the percent Martinez-Vila evolution indices (EI%). Semiquantitative visual analysis of SPECT images was performed in 6 cortical regions relevant for carotid artery territory. Both the extent and the intensity of cortical reduced ECD uptake were calculated, leading to an 'ischemia' score, corresponding to the sum of regions of interest (ROI) where ECD uptake was between 40 and 80% of the contralateral healthy hemisphere, and an 'irreversibly damaged tissue' (IDT) score, corresponding to an uptake below 40%, and a total score (ischemia + IDT). Each patient was assigned to one of three patterns: (1) pattern I with severe ECD cortical uptake reduction defined by at least one ROI with uptake under 40%, (2) pattern II with moderate ECD cortical uptake reduction (40-80%) only and (3) pattern III with normal ECD uptake. There were 11 patients (46%) with pattern I ECD-SPECT. This group had almost invariably (10/11 patients) a poor outcome. The 12 patients (50%) classified in pattern II had a variable clinical outcome, ranging from improvement to deterioration. The single patient with a normal SPECT (pattern III) had a full clinical recovery. Both total score and IDT score were strongly significantly correlated with neurological recovery EI% (respectively p = 0.006 and 0.004). Their predictive value was significantly higher than, and independent of, day 0 neurological evaluation. No patient had an increased ECD uptake. Our results show that the degree of ECD cortical uptake reduction, measured on early brain SPECT, is a strong predictor of neurological recovery. ECD-SPECT data have a higher predictive value than day 0 neurological evaluation. The apparently better predictive value of ECD over hexamethylpropyleneamine oxime may reflect this tracer's brain retention mechanisms which are weighted
doi_str_mv 10.1159/000016092
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_72240960</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72240960</sourcerecordid><originalsourceid>FETCH-LOGICAL-p122t-85a9bec712fb84c5c1a3c8f47d6415098a9d0a5620342fd7df05ed29637e5ef83</originalsourceid><addsrcrecordid>eNo1kE1LxDAURbNQnHF04R-QrEQX1SRtmmYpQ_2AAQXHdUmTF6faNjVJhYI_3orj21w493AXD6EzSq4p5fKGzEdzItkBWlJCeSKFIAt0HML73OS0oEdoQYkUlDC2RN-l8u2EL6XsrrY6gbibWj2FCE2vImDTdOBx7VXT45fncr3Fg4oRfB_wTOIOsNLj7A07FQA7i0P07mOmAQ8eTKOj8-GX9zB617q3RqsWe9DuC_x0gg6tagOc7nOFXu_K7foh2TzdP65vN8lAGYtJwZWsQQvKbF1kmmuqUl3YTJg8o5zIQklDFM8ZSTNmjTCWcDBM5qkADrZIV-jib3fw7nOEEKuuCRraVvXgxlAJxjIiczKL53txrDsw1eCbTvmp-v9X-gOtnmqD</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72240960</pqid></control><display><type>article</type><title>Early (99m)Tc-ethylcysteinate dimer brain SPECT patterns in the acute phase of stroke as predictors of neurological recovery</title><source>MEDLINE</source><source>Karger Journals</source><creator>Mahagne, M H ; Darcourt, J ; Migneco, O ; Fournier, J P ; Thiercelin, D ; Ducoeur, S ; Bertrand, F ; Bussière, F ; Chatel, M ; Baron, J C</creator><creatorcontrib>Mahagne, M H ; Darcourt, J ; Migneco, O ; Fournier, J P ; Thiercelin, D ; Ducoeur, S ; Bertrand, F ; Bussière, F ; Chatel, M ; Baron, J C</creatorcontrib><description>Accurate prediction of outcome in acute stroke would help in identifying subgroups of patients for therapeutic trials and intravenous thrombolysis. The purpose of this study was to prospectively test the hypothesis that brain SPECT, with (99m)Tc-L, L-ethylcysteinate dimer (ECD), a tracer sensitive to cell function, performed in the first hours after stroke onset, adds predictive power to concomitant neurological evaluation. Twenty-four patients with a first-ever middle cerebral artery stroke were prospectively studied with ECD-SPECT within 12 h after stroke onset. Neurological evaluation was performed using Orgogozo's scale at admission and 3 months later in order to calculate the percent Martinez-Vila evolution indices (EI%). Semiquantitative visual analysis of SPECT images was performed in 6 cortical regions relevant for carotid artery territory. Both the extent and the intensity of cortical reduced ECD uptake were calculated, leading to an 'ischemia' score, corresponding to the sum of regions of interest (ROI) where ECD uptake was between 40 and 80% of the contralateral healthy hemisphere, and an 'irreversibly damaged tissue' (IDT) score, corresponding to an uptake below 40%, and a total score (ischemia + IDT). Each patient was assigned to one of three patterns: (1) pattern I with severe ECD cortical uptake reduction defined by at least one ROI with uptake under 40%, (2) pattern II with moderate ECD cortical uptake reduction (40-80%) only and (3) pattern III with normal ECD uptake. There were 11 patients (46%) with pattern I ECD-SPECT. This group had almost invariably (10/11 patients) a poor outcome. The 12 patients (50%) classified in pattern II had a variable clinical outcome, ranging from improvement to deterioration. The single patient with a normal SPECT (pattern III) had a full clinical recovery. Both total score and IDT score were strongly significantly correlated with neurological recovery EI% (respectively p = 0.006 and 0.004). Their predictive value was significantly higher than, and independent of, day 0 neurological evaluation. No patient had an increased ECD uptake. Our results show that the degree of ECD cortical uptake reduction, measured on early brain SPECT, is a strong predictor of neurological recovery. ECD-SPECT data have a higher predictive value than day 0 neurological evaluation. The apparently better predictive value of ECD over hexamethylpropyleneamine oxime may reflect this tracer's brain retention mechanisms which are weighted more towards cell function than towards perfusion. ECD-SPECT is easily obtainable and may help in selecting out from therapy those patients who are likely to have either very good or very poor spontaneous outcome, and thus improve the assessment of acute stroke and the choice of therapeutic strategy.</description><identifier>ISSN: 1015-9770</identifier><identifier>DOI: 10.1159/000016092</identifier><identifier>PMID: 10971022</identifier><language>eng</language><publisher>Switzerland</publisher><subject>Acute Disease ; Aged ; Aged, 80 and over ; Cysteine - analogs &amp; derivatives ; Female ; Humans ; Male ; Middle Aged ; Neurologic Examination ; Organotechnetium Compounds ; Predictive Value of Tests ; Prognosis ; Prospective Studies ; Radiopharmaceuticals ; Recovery of Function ; Stroke - diagnostic imaging ; Stroke Rehabilitation ; Tomography, Emission-Computed, Single-Photon - methods ; Tomography, X-Ray Computed</subject><ispartof>Cerebrovascular diseases (Basel, Switzerland), 2000-09, Vol.10 (5), p.364-373</ispartof><rights>Copyright 2000 S. Karger AG, Basel</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786,27931,27932</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10971022$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mahagne, M H</creatorcontrib><creatorcontrib>Darcourt, J</creatorcontrib><creatorcontrib>Migneco, O</creatorcontrib><creatorcontrib>Fournier, J P</creatorcontrib><creatorcontrib>Thiercelin, D</creatorcontrib><creatorcontrib>Ducoeur, S</creatorcontrib><creatorcontrib>Bertrand, F</creatorcontrib><creatorcontrib>Bussière, F</creatorcontrib><creatorcontrib>Chatel, M</creatorcontrib><creatorcontrib>Baron, J C</creatorcontrib><title>Early (99m)Tc-ethylcysteinate dimer brain SPECT patterns in the acute phase of stroke as predictors of neurological recovery</title><title>Cerebrovascular diseases (Basel, Switzerland)</title><addtitle>Cerebrovasc Dis</addtitle><description>Accurate prediction of outcome in acute stroke would help in identifying subgroups of patients for therapeutic trials and intravenous thrombolysis. The purpose of this study was to prospectively test the hypothesis that brain SPECT, with (99m)Tc-L, L-ethylcysteinate dimer (ECD), a tracer sensitive to cell function, performed in the first hours after stroke onset, adds predictive power to concomitant neurological evaluation. Twenty-four patients with a first-ever middle cerebral artery stroke were prospectively studied with ECD-SPECT within 12 h after stroke onset. Neurological evaluation was performed using Orgogozo's scale at admission and 3 months later in order to calculate the percent Martinez-Vila evolution indices (EI%). Semiquantitative visual analysis of SPECT images was performed in 6 cortical regions relevant for carotid artery territory. Both the extent and the intensity of cortical reduced ECD uptake were calculated, leading to an 'ischemia' score, corresponding to the sum of regions of interest (ROI) where ECD uptake was between 40 and 80% of the contralateral healthy hemisphere, and an 'irreversibly damaged tissue' (IDT) score, corresponding to an uptake below 40%, and a total score (ischemia + IDT). Each patient was assigned to one of three patterns: (1) pattern I with severe ECD cortical uptake reduction defined by at least one ROI with uptake under 40%, (2) pattern II with moderate ECD cortical uptake reduction (40-80%) only and (3) pattern III with normal ECD uptake. There were 11 patients (46%) with pattern I ECD-SPECT. This group had almost invariably (10/11 patients) a poor outcome. The 12 patients (50%) classified in pattern II had a variable clinical outcome, ranging from improvement to deterioration. The single patient with a normal SPECT (pattern III) had a full clinical recovery. Both total score and IDT score were strongly significantly correlated with neurological recovery EI% (respectively p = 0.006 and 0.004). Their predictive value was significantly higher than, and independent of, day 0 neurological evaluation. No patient had an increased ECD uptake. Our results show that the degree of ECD cortical uptake reduction, measured on early brain SPECT, is a strong predictor of neurological recovery. ECD-SPECT data have a higher predictive value than day 0 neurological evaluation. The apparently better predictive value of ECD over hexamethylpropyleneamine oxime may reflect this tracer's brain retention mechanisms which are weighted more towards cell function than towards perfusion. ECD-SPECT is easily obtainable and may help in selecting out from therapy those patients who are likely to have either very good or very poor spontaneous outcome, and thus improve the assessment of acute stroke and the choice of therapeutic strategy.</description><subject>Acute Disease</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Cysteine - analogs &amp; derivatives</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neurologic Examination</subject><subject>Organotechnetium Compounds</subject><subject>Predictive Value of Tests</subject><subject>Prognosis</subject><subject>Prospective Studies</subject><subject>Radiopharmaceuticals</subject><subject>Recovery of Function</subject><subject>Stroke - diagnostic imaging</subject><subject>Stroke Rehabilitation</subject><subject>Tomography, Emission-Computed, Single-Photon - methods</subject><subject>Tomography, X-Ray Computed</subject><issn>1015-9770</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kE1LxDAURbNQnHF04R-QrEQX1SRtmmYpQ_2AAQXHdUmTF6faNjVJhYI_3orj21w493AXD6EzSq4p5fKGzEdzItkBWlJCeSKFIAt0HML73OS0oEdoQYkUlDC2RN-l8u2EL6XsrrY6gbibWj2FCE2vImDTdOBx7VXT45fncr3Fg4oRfB_wTOIOsNLj7A07FQA7i0P07mOmAQ8eTKOj8-GX9zB617q3RqsWe9DuC_x0gg6tagOc7nOFXu_K7foh2TzdP65vN8lAGYtJwZWsQQvKbF1kmmuqUl3YTJg8o5zIQklDFM8ZSTNmjTCWcDBM5qkADrZIV-jib3fw7nOEEKuuCRraVvXgxlAJxjIiczKL53txrDsw1eCbTvmp-v9X-gOtnmqD</recordid><startdate>200009</startdate><enddate>200009</enddate><creator>Mahagne, M H</creator><creator>Darcourt, J</creator><creator>Migneco, O</creator><creator>Fournier, J P</creator><creator>Thiercelin, D</creator><creator>Ducoeur, S</creator><creator>Bertrand, F</creator><creator>Bussière, F</creator><creator>Chatel, M</creator><creator>Baron, J C</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200009</creationdate><title>Early (99m)Tc-ethylcysteinate dimer brain SPECT patterns in the acute phase of stroke as predictors of neurological recovery</title><author>Mahagne, M H ; Darcourt, J ; Migneco, O ; Fournier, J P ; Thiercelin, D ; Ducoeur, S ; Bertrand, F ; Bussière, F ; Chatel, M ; Baron, J C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p122t-85a9bec712fb84c5c1a3c8f47d6415098a9d0a5620342fd7df05ed29637e5ef83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Acute Disease</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Cysteine - analogs &amp; derivatives</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neurologic Examination</topic><topic>Organotechnetium Compounds</topic><topic>Predictive Value of Tests</topic><topic>Prognosis</topic><topic>Prospective Studies</topic><topic>Radiopharmaceuticals</topic><topic>Recovery of Function</topic><topic>Stroke - diagnostic imaging</topic><topic>Stroke Rehabilitation</topic><topic>Tomography, Emission-Computed, Single-Photon - methods</topic><topic>Tomography, X-Ray Computed</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mahagne, M H</creatorcontrib><creatorcontrib>Darcourt, J</creatorcontrib><creatorcontrib>Migneco, O</creatorcontrib><creatorcontrib>Fournier, J P</creatorcontrib><creatorcontrib>Thiercelin, D</creatorcontrib><creatorcontrib>Ducoeur, S</creatorcontrib><creatorcontrib>Bertrand, F</creatorcontrib><creatorcontrib>Bussière, F</creatorcontrib><creatorcontrib>Chatel, M</creatorcontrib><creatorcontrib>Baron, J C</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Cerebrovascular diseases (Basel, Switzerland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mahagne, M H</au><au>Darcourt, J</au><au>Migneco, O</au><au>Fournier, J P</au><au>Thiercelin, D</au><au>Ducoeur, S</au><au>Bertrand, F</au><au>Bussière, F</au><au>Chatel, M</au><au>Baron, J C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Early (99m)Tc-ethylcysteinate dimer brain SPECT patterns in the acute phase of stroke as predictors of neurological recovery</atitle><jtitle>Cerebrovascular diseases (Basel, Switzerland)</jtitle><addtitle>Cerebrovasc Dis</addtitle><date>2000-09</date><risdate>2000</risdate><volume>10</volume><issue>5</issue><spage>364</spage><epage>373</epage><pages>364-373</pages><issn>1015-9770</issn><abstract>Accurate prediction of outcome in acute stroke would help in identifying subgroups of patients for therapeutic trials and intravenous thrombolysis. The purpose of this study was to prospectively test the hypothesis that brain SPECT, with (99m)Tc-L, L-ethylcysteinate dimer (ECD), a tracer sensitive to cell function, performed in the first hours after stroke onset, adds predictive power to concomitant neurological evaluation. Twenty-four patients with a first-ever middle cerebral artery stroke were prospectively studied with ECD-SPECT within 12 h after stroke onset. Neurological evaluation was performed using Orgogozo's scale at admission and 3 months later in order to calculate the percent Martinez-Vila evolution indices (EI%). Semiquantitative visual analysis of SPECT images was performed in 6 cortical regions relevant for carotid artery territory. Both the extent and the intensity of cortical reduced ECD uptake were calculated, leading to an 'ischemia' score, corresponding to the sum of regions of interest (ROI) where ECD uptake was between 40 and 80% of the contralateral healthy hemisphere, and an 'irreversibly damaged tissue' (IDT) score, corresponding to an uptake below 40%, and a total score (ischemia + IDT). Each patient was assigned to one of three patterns: (1) pattern I with severe ECD cortical uptake reduction defined by at least one ROI with uptake under 40%, (2) pattern II with moderate ECD cortical uptake reduction (40-80%) only and (3) pattern III with normal ECD uptake. There were 11 patients (46%) with pattern I ECD-SPECT. This group had almost invariably (10/11 patients) a poor outcome. The 12 patients (50%) classified in pattern II had a variable clinical outcome, ranging from improvement to deterioration. The single patient with a normal SPECT (pattern III) had a full clinical recovery. Both total score and IDT score were strongly significantly correlated with neurological recovery EI% (respectively p = 0.006 and 0.004). Their predictive value was significantly higher than, and independent of, day 0 neurological evaluation. No patient had an increased ECD uptake. Our results show that the degree of ECD cortical uptake reduction, measured on early brain SPECT, is a strong predictor of neurological recovery. ECD-SPECT data have a higher predictive value than day 0 neurological evaluation. The apparently better predictive value of ECD over hexamethylpropyleneamine oxime may reflect this tracer's brain retention mechanisms which are weighted more towards cell function than towards perfusion. ECD-SPECT is easily obtainable and may help in selecting out from therapy those patients who are likely to have either very good or very poor spontaneous outcome, and thus improve the assessment of acute stroke and the choice of therapeutic strategy.</abstract><cop>Switzerland</cop><pmid>10971022</pmid><doi>10.1159/000016092</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1015-9770
ispartof Cerebrovascular diseases (Basel, Switzerland), 2000-09, Vol.10 (5), p.364-373
issn 1015-9770
language eng
recordid cdi_proquest_miscellaneous_72240960
source MEDLINE; Karger Journals
subjects Acute Disease
Aged
Aged, 80 and over
Cysteine - analogs & derivatives
Female
Humans
Male
Middle Aged
Neurologic Examination
Organotechnetium Compounds
Predictive Value of Tests
Prognosis
Prospective Studies
Radiopharmaceuticals
Recovery of Function
Stroke - diagnostic imaging
Stroke Rehabilitation
Tomography, Emission-Computed, Single-Photon - methods
Tomography, X-Ray Computed
title Early (99m)Tc-ethylcysteinate dimer brain SPECT patterns in the acute phase of stroke as predictors of neurological recovery
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T11%3A37%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Early%20(99m)Tc-ethylcysteinate%20dimer%20brain%20SPECT%20patterns%20in%20the%20acute%20phase%20of%20stroke%20as%20predictors%20of%20neurological%20recovery&rft.jtitle=Cerebrovascular%20diseases%20(Basel,%20Switzerland)&rft.au=Mahagne,%20M%20H&rft.date=2000-09&rft.volume=10&rft.issue=5&rft.spage=364&rft.epage=373&rft.pages=364-373&rft.issn=1015-9770&rft_id=info:doi/10.1159/000016092&rft_dat=%3Cproquest_pubme%3E72240960%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72240960&rft_id=info:pmid/10971022&rfr_iscdi=true